Showing results (2091-2100 of 2,194) with videos related to

Sort By:
Pageof 220
Prostaglandins, Leukotrienes, and Essential Fatty Acids|April 13, 2019
Fish oil protects the liver from parenteral nutrition-induced injury via GPR120-mediated PPARγ signalingGillian L Fell, Bennet S Cho, Duy T Dao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2004
Human parvovirus B19 transgenic mice become susceptible to polyarthritisNaruhiko Takasawa, Yasuhiko Munakata, Keiko Kumura Ishii, et al.
Biomedical Reports|October 11, 2021
Ischemic hepatitis with infectious endocarditis: A case reportHiroshi Okano, Ryo Okado, Hisato Ito, et al.
DEN Open|July 25, 2022
A novel, simple, and dedicated device for endoscopic mucosal defect closureYohei Nose, Kohei Takizawa, Kazuo Shiotsuki, et al.
Human Pathology|May 28, 2013
Distinct morphologic, phenotypic, and clinical-course characteristics of indolent peripheral T-cell lymphomaEiko Hayashi, Katsuyoshi Takata, Yasuharu Sato, et al.
Hypertension (Dallas, Tex. : 1979)|September 22, 2001
Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphataseY Shibasaki, H Matsubara, Y Nozawa, et al.
Endocrinology|December 15, 2007
Interleukin (IL)-17A stimulates IL-8 secretion, cyclooxygensase-2 expression, and cell proliferation of endometriotic stromal cellsTetsuya Hirata, Yutaka Osuga, Kahori Hamasaki, et al.
Internal Medicine (Tokyo, Japan)|January 11, 2019
Hepatic Injury without Granulomatous Formation Associated with Intravesical Bacillus Calmette-Guérin TherapyHiroshi Okano, Hiroki Asakawa, Kenji Nose, et al.
International Journal of Hematology|January 26, 2022
Apixaban in Japanese patients with cancer-associated venous thromboembolism: a multi-center phase II trialYoshinori Imamura, Kazunori Otsui, Kenta Mori, et al.
Circulation Research|January 5, 2001
Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivationS Fujiyama, H Matsubara, Y Nozawa, et al.
Pageof 220